Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia.
Cummins KD, Jane SM, Ninkovic S, Bazargan A, Filshie R, Sutrave G, Hertzberg M, Scott A, Lane S, Yannakou CK, Ritchie D, D'Rozario J, Black J, Bavishi K, Wei A.
Cummins KD, et al.
Blood Cancer J. 2014 Aug 8;4(8):e237. doi: 10.1038/bcj.2014.59.
Blood Cancer J. 2014.
PMID: 25105536
Free PMC article.
No abstract available.